HUTCHMED (China) (HCM) Capital Expenditures (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Capital Expenditures of -$2.9 million for Q2 2021, down 44.95% year-over-year from -$5.2 million in Q2 2020, and up 52.83% quarter-over-quarter from -$6.1 million in Q1 2021.
HUTCHMED (China) (HCM) Capital Expenditures (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Capital Expenditures for 4 consecutive years, with -$2.9 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Capital Expenditures fell 44.95% year-over-year to -$2.9 million; the TTM figure through Jun 2021 stood at -$13.0 million (down 47.83% YoY), while the FY2025 annual figure was -$14.1 million, up 21.11% from the prior year.
- Capital Expenditures improved to -$2.9 million in Q2 2021 per HCM's latest filing, from -$6.1 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $3.6 million in Q4 2018 and bottomed at -$6.1 million in Q1 2021.
- Historically, Capital Expenditures has averaged -$1.8 million across 4 years, with a median of -$1.9 million in 2019.
- Annual changes were most pronounced in 2019 — Capital Expenditures tumbled 226.81% — and 2020, when it gained 20.75%.
- HUTCHMED (China)'s Capital Expenditures stood at $3.6 million in 2018, then tumbled by 182.64% to -$3.0 million in 2019, then jumped by 33.21% to -$2.0 million in 2020, then sank by 44.95% to -$2.9 million in 2021.
- Business Quant data shows HCM's Capital Expenditures at -$2.9 million in Q2 2021, -$6.1 million in Q1 2021, and -$2.0 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -2.86 Mn |
| Jun 30, 2021 | -2.86 Mn |
| Mar 31, 2021 | -6.06 Mn |
| Mar 31, 2021 | -6.06 Mn |
| Jun 30, 2020 | -1.97 Mn |
| Jun 30, 2020 | -1.97 Mn |
| Mar 31, 2020 | -2.09 Mn |
| Mar 31, 2020 | -2.09 Mn |
| Dec 31, 2019 | -2.95 Mn |
| Dec 31, 2019 | -2.95 Mn |
| Sep 30, 2019 | -1.77 Mn |
| Sep 30, 2019 | -1.77 Mn |
| Jun 30, 2019 | -2.49 Mn |
| Jun 30, 2019 | -2.49 Mn |
| Mar 31, 2019 | -1.36 Mn |
| Mar 31, 2019 | -1.36 Mn |
| Dec 31, 2018 | 3.57 Mn |
| Dec 31, 2018 | 3.57 Mn |
| Sep 30, 2018 | -1.35 Mn |
| Sep 30, 2018 | -1.35 Mn |